Improving Survival Rates Through Targeted Colon Cancer Treatments
Colon cancer remains one of the most prevalent malignancies globally, but advancements in targeted therapy have significantly improved patient survival rates. Unlike traditional chemotherapy, targeted treatments focus on specific molecules involved in cancer growth and spread. By blocking these pathways, doctors can slow tumor progression while minimizing damage to healthy tissues. This personalized approach represents a crucial leap forward in oncology care, offering patients new hope and better quality of life.
Click to Visit Site